Early Monitoring and Subsequent Gain of Tacrolimus Time-In-Therapeutic Range May Improve Clinical Outcomes After Living Kidney Transplantation
Conclusions:
The 6-month TTR identified patients at higher risk of worse outcomes. The subsequent gain of TTR may contribute to better transplant outcomes.
Source: Therapeutic Drug Monitoring - Category: Drugs & Pharmacology Tags: Original Article Source Type: research
More News: Drugs & Pharmacology | Kidney Transplant | Kidney Transplantation | Prograf | Tacrolimus | Transplant Surgery | Transplants | Urology & Nephrology